Cargando…

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer

Cancer-specific plectin (CSP) is a pro-tumorigenic protein selectively expressed on the cell surface of major cancers, including ovarian cancer (OC). Despite its assessable localization, abundance, and functional significance, the therapeutic efficacy of targeting CSP remains unexplored. Here, we ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez, Samantha M., Dimastromatteo, Julien, Landen, Charles N., Kelly, Kimberly A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466582/ https://www.ncbi.nlm.nih.gov/pubmed/34571866 http://dx.doi.org/10.3390/cells10092218

Ejemplares similares

Plectin in Cancer: From Biomarker to Therapeutic Target
por: Perez, Samantha M., et al.
Publicado: (2021)

Monoclonal antibody mapping of structural and functional plectin epitopes
Publicado: (1991)

Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer
por: Dasa, Siva Sai Krishna, et al.
Publicado: (2018)

Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer
por: Konkalmatt, Prasad R., et al.
Publicado: (2013)

Plectin in Health and Disease
por: Wiche, Gerhard
Publicado: (2022)

Thioridazine has potent antitumor effects on lung cancer stem-like cells
por: Shen, Jiani, et al.
Publicado: (2017)

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells
por: Yin, Zhengna, et al.
Publicado: (2017)

Occurrence and immunolocalization of plectin in tissues
Publicado: (1983)

Plectin in Skin Fragility Disorders
por: Kiritsi, Dimitra, et al.
Publicado: (2021)

A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
por: Wu, Xiaoqiong, et al.
Publicado: (2018)

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities
por: Bjorck, Pia, et al.
Publicado: (2015)

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
por: Chen, Yujin, et al.
Publicado: (2018)

Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging
por: Chen, Xiao, et al.
Publicado: (2018)

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.
por: Hird, V., et al.
Publicado: (1993)

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021)

Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer
por: Kanda, Mizuki, et al.
Publicado: (2022)

POTENT AND SELECTIVE A2AR MONOCLONAL ANTIBODY ANTAGONIST FOR THE TREATMENT OF CANCER
por: Hu, Changyun, et al.
Publicado: (2023)

Binding of Integrin α6β4 to Plectin Prevents Plectin Association with F-Actin but Does Not Interfere with Intermediate Filament Binding
por: Geerts, Dirk, et al.
Publicado: (1999)

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
por: Liu, Donglin, et al.
Publicado: (2014)

Effects of Plectin Depletion on Keratin Network Dynamics and Organization
por: Moch, Marcin, et al.
Publicado: (2016)

Determining the mechanical properties of plectin in mouse myoblasts and keratinocytes
por: Bonakdar, Navid, et al.
Publicado: (2015)

Identifying Plectin Isoform Functions through Animal Models
por: Castañón, Maria J., et al.
Publicado: (2021)

Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment
por: Cheng, Chiung-Chi, et al.
Publicado: (2017)

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model
por: Chang, De-Kuan, et al.
Publicado: (2015)

Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer
por: Koivusalo, Saara, et al.
Publicado: (2022)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

The rod domain is not essential for the function of plectin in maintaining tissue integrity
por: Ketema, Mirjam, et al.
Publicado: (2015)

Plectin-Mediated Intermediate Filament Functions: Why Isoforms Matter
por: Wiche, Gerhard
Publicado: (2021)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects
por: West, Alison C., et al.
Publicado: (2012)

Molecular imaging of pulmonary diseases
por: Dimastromatteo, Julien, et al.
Publicado: (2018)

Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
por: Wu, Ying, et al.
Publicado: (2020)

Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2022)

Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers
por: Okita, Kouki, et al.
Publicado: (2020)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer
por: Guo, Xiaojia, et al.
Publicado: (2016)

Plectin–intermediate filament partnership in skin, skeletal muscle, and peripheral nerve
por: Castañón, Maria J., et al.
Publicado: (2013)

Downstream effects of plectin mutations in epidermolysis bullosa simplex with muscular dystrophy
por: Winter, Lilli, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2vlb067kb4k41d25tvi92v8oq6